Search

Your search keyword '"BOUGHEY, JUDY C."' showing total 87 results
Start Over Author "BOUGHEY, JUDY C." Publisher american association for cancer research (aacr)
87 results on '"BOUGHEY, JUDY C."'

1. Supplementary Table S3 from Neoadjuvant Trebananib plus Paclitaxel-based Chemotherapy for Stage II/III Breast Cancer in the Adaptively Randomized I-SPY2 Trial—Efficacy and Biomarker Discovery

Author

Albain, Kathy S., primary, Yau, Christina, primary, Petricoin, Emanuel F., primary, Wolf, Denise M., primary, Lang, Julie E., primary, Chien, A. Jo, primary, Haddad, Tufia, primary, Forero-Torres, Andres, primary, Wallace, Anne M., primary, Kaplan, Henry, primary, Pusztai, Lajos, primary, Euhus, David, primary, Nanda, Rita, primary, Elias, Anthony D., primary, Clark, Amy S., primary, Godellas, Constantine, primary, Boughey, Judy C., primary, Isaacs, Claudine, primary, Tripathy, Debu, primary, Lu, Janice, primary, Yung, Rachel L., primary, Gallagher, Rosa I., primary, Wulfkuhle, Julia D., primary, Brown-Swigart, Lamorna, primary, Krings, Gregor, primary, Chen, Yunn Yi, primary, Potter, David A., primary, Stringer-Reasor, Erica, primary, Blair, Sarah, primary, Asare, Smita M., primary, Wilson, Amy, primary, Hirst, Gillian L., primary, Singhrao, Ruby, primary, Buxton, Meredith, primary, Clennell, Julia L., primary, Sanil, Ashish, primary, Berry, Scott, primary, Asare, Adam L., primary, Matthews, Jeffrey B., primary, DeMichele, Angela M., primary, Hylton, Nola M., primary, Melisko, Michelle, primary, Perlmutter, Jane, primary, Rugo, Hope S., primary, Symmans, W. Fraser, primary, van't Veer, Laura J., primary, Yee, Douglas, primary, Berry, Donald A., primary, and Esserman, Laura J., primary

Published
2024
Full Text
View/download PDF

2. Supplementary Table S4 from Neoadjuvant Trebananib plus Paclitaxel-based Chemotherapy for Stage II/III Breast Cancer in the Adaptively Randomized I-SPY2 Trial—Efficacy and Biomarker Discovery

Author

Albain, Kathy S., primary, Yau, Christina, primary, Petricoin, Emanuel F., primary, Wolf, Denise M., primary, Lang, Julie E., primary, Chien, A. Jo, primary, Haddad, Tufia, primary, Forero-Torres, Andres, primary, Wallace, Anne M., primary, Kaplan, Henry, primary, Pusztai, Lajos, primary, Euhus, David, primary, Nanda, Rita, primary, Elias, Anthony D., primary, Clark, Amy S., primary, Godellas, Constantine, primary, Boughey, Judy C., primary, Isaacs, Claudine, primary, Tripathy, Debu, primary, Lu, Janice, primary, Yung, Rachel L., primary, Gallagher, Rosa I., primary, Wulfkuhle, Julia D., primary, Brown-Swigart, Lamorna, primary, Krings, Gregor, primary, Chen, Yunn Yi, primary, Potter, David A., primary, Stringer-Reasor, Erica, primary, Blair, Sarah, primary, Asare, Smita M., primary, Wilson, Amy, primary, Hirst, Gillian L., primary, Singhrao, Ruby, primary, Buxton, Meredith, primary, Clennell, Julia L., primary, Sanil, Ashish, primary, Berry, Scott, primary, Asare, Adam L., primary, Matthews, Jeffrey B., primary, DeMichele, Angela M., primary, Hylton, Nola M., primary, Melisko, Michelle, primary, Perlmutter, Jane, primary, Rugo, Hope S., primary, Symmans, W. Fraser, primary, van't Veer, Laura J., primary, Yee, Douglas, primary, Berry, Donald A., primary, and Esserman, Laura J., primary

Published
2024
Full Text
View/download PDF

3. Data from Neoadjuvant Trebananib plus Paclitaxel-based Chemotherapy for Stage II/III Breast Cancer in the Adaptively Randomized I-SPY2 Trial—Efficacy and Biomarker Discovery

Author

Albain, Kathy S., primary, Yau, Christina, primary, Petricoin, Emanuel F., primary, Wolf, Denise M., primary, Lang, Julie E., primary, Chien, A. Jo, primary, Haddad, Tufia, primary, Forero-Torres, Andres, primary, Wallace, Anne M., primary, Kaplan, Henry, primary, Pusztai, Lajos, primary, Euhus, David, primary, Nanda, Rita, primary, Elias, Anthony D., primary, Clark, Amy S., primary, Godellas, Constantine, primary, Boughey, Judy C., primary, Isaacs, Claudine, primary, Tripathy, Debu, primary, Lu, Janice, primary, Yung, Rachel L., primary, Gallagher, Rosa I., primary, Wulfkuhle, Julia D., primary, Brown-Swigart, Lamorna, primary, Krings, Gregor, primary, Chen, Yunn Yi, primary, Potter, David A., primary, Stringer-Reasor, Erica, primary, Blair, Sarah, primary, Asare, Smita M., primary, Wilson, Amy, primary, Hirst, Gillian L., primary, Singhrao, Ruby, primary, Buxton, Meredith, primary, Clennell, Julia L., primary, Sanil, Ashish, primary, Berry, Scott, primary, Asare, Adam L., primary, Matthews, Jeffrey B., primary, DeMichele, Angela M., primary, Hylton, Nola M., primary, Melisko, Michelle, primary, Perlmutter, Jane, primary, Rugo, Hope S., primary, Symmans, W. Fraser, primary, van't Veer, Laura J., primary, Yee, Douglas, primary, Berry, Donald A., primary, and Esserman, Laura J., primary

Published
2024
Full Text
View/download PDF

4. Supplementary Table S1 from Neoadjuvant Trebananib plus Paclitaxel-based Chemotherapy for Stage II/III Breast Cancer in the Adaptively Randomized I-SPY2 Trial—Efficacy and Biomarker Discovery

Author

Albain, Kathy S., primary, Yau, Christina, primary, Petricoin, Emanuel F., primary, Wolf, Denise M., primary, Lang, Julie E., primary, Chien, A. Jo, primary, Haddad, Tufia, primary, Forero-Torres, Andres, primary, Wallace, Anne M., primary, Kaplan, Henry, primary, Pusztai, Lajos, primary, Euhus, David, primary, Nanda, Rita, primary, Elias, Anthony D., primary, Clark, Amy S., primary, Godellas, Constantine, primary, Boughey, Judy C., primary, Isaacs, Claudine, primary, Tripathy, Debu, primary, Lu, Janice, primary, Yung, Rachel L., primary, Gallagher, Rosa I., primary, Wulfkuhle, Julia D., primary, Brown-Swigart, Lamorna, primary, Krings, Gregor, primary, Chen, Yunn Yi, primary, Potter, David A., primary, Stringer-Reasor, Erica, primary, Blair, Sarah, primary, Asare, Smita M., primary, Wilson, Amy, primary, Hirst, Gillian L., primary, Singhrao, Ruby, primary, Buxton, Meredith, primary, Clennell, Julia L., primary, Sanil, Ashish, primary, Berry, Scott, primary, Asare, Adam L., primary, Matthews, Jeffrey B., primary, DeMichele, Angela M., primary, Hylton, Nola M., primary, Melisko, Michelle, primary, Perlmutter, Jane, primary, Rugo, Hope S., primary, Symmans, W. Fraser, primary, van't Veer, Laura J., primary, Yee, Douglas, primary, Berry, Donald A., primary, and Esserman, Laura J., primary

Published
2024
Full Text
View/download PDF

5. Supplementary Table S3 from Neoadjuvant Trebananib plus Paclitaxel-based Chemotherapy for Stage II/III Breast Cancer in the Adaptively Randomized I-SPY2 Trial—Efficacy and Biomarker Discovery

Author

Albain, Kathy S., primary, Yau, Christina, primary, Petricoin, Emanuel F., primary, Wolf, Denise M., primary, Lang, Julie E., primary, Chien, A. Jo, primary, Haddad, Tufia, primary, Forero-Torres, Andres, primary, Wallace, Anne M., primary, Kaplan, Henry, primary, Pusztai, Lajos, primary, Euhus, David, primary, Nanda, Rita, primary, Elias, Anthony D., primary, Clark, Amy S., primary, Godellas, Constantine, primary, Boughey, Judy C., primary, Isaacs, Claudine, primary, Tripathy, Debu, primary, Lu, Janice, primary, Yung, Rachel L., primary, Gallagher, Rosa I., primary, Wulfkuhle, Julia D., primary, Brown-Swigart, Lamorna, primary, Krings, Gregor, primary, Chen, Yunn Yi, primary, Potter, David A., primary, Stringer-Reasor, Erica, primary, Blair, Sarah, primary, Asare, Smita M., primary, Wilson, Amy, primary, Hirst, Gillian L., primary, Singhrao, Ruby, primary, Buxton, Meredith, primary, Clennell, Julia L., primary, Sanil, Ashish, primary, Berry, Scott, primary, Asare, Adam L., primary, Matthews, Jeffrey B., primary, DeMichele, Angela M., primary, Hylton, Nola M., primary, Melisko, Michelle, primary, Perlmutter, Jane, primary, Rugo, Hope S., primary, Symmans, W. Fraser, primary, van't Veer, Laura J., primary, Yee, Douglas, primary, Berry, Donald A., primary, and Esserman, Laura J., primary

Published
2024
Full Text
View/download PDF

6. Supplementary Table S1 from Neoadjuvant Trebananib plus Paclitaxel-based Chemotherapy for Stage II/III Breast Cancer in the Adaptively Randomized I-SPY2 Trial—Efficacy and Biomarker Discovery

Author

Albain, Kathy S., primary, Yau, Christina, primary, Petricoin, Emanuel F., primary, Wolf, Denise M., primary, Lang, Julie E., primary, Chien, A. Jo, primary, Haddad, Tufia, primary, Forero-Torres, Andres, primary, Wallace, Anne M., primary, Kaplan, Henry, primary, Pusztai, Lajos, primary, Euhus, David, primary, Nanda, Rita, primary, Elias, Anthony D., primary, Clark, Amy S., primary, Godellas, Constantine, primary, Boughey, Judy C., primary, Isaacs, Claudine, primary, Tripathy, Debu, primary, Lu, Janice, primary, Yung, Rachel L., primary, Gallagher, Rosa I., primary, Wulfkuhle, Julia D., primary, Brown-Swigart, Lamorna, primary, Krings, Gregor, primary, Chen, Yunn Yi, primary, Potter, David A., primary, Stringer-Reasor, Erica, primary, Blair, Sarah, primary, Asare, Smita M., primary, Wilson, Amy, primary, Hirst, Gillian L., primary, Singhrao, Ruby, primary, Buxton, Meredith, primary, Clennell, Julia L., primary, Sanil, Ashish, primary, Berry, Scott, primary, Asare, Adam L., primary, Matthews, Jeffrey B., primary, DeMichele, Angela M., primary, Hylton, Nola M., primary, Melisko, Michelle, primary, Perlmutter, Jane, primary, Rugo, Hope S., primary, Symmans, W. Fraser, primary, van't Veer, Laura J., primary, Yee, Douglas, primary, Berry, Donald A., primary, and Esserman, Laura J., primary

Published
2024
Full Text
View/download PDF

7. Supplementary Table S4 from Neoadjuvant Trebananib plus Paclitaxel-based Chemotherapy for Stage II/III Breast Cancer in the Adaptively Randomized I-SPY2 Trial—Efficacy and Biomarker Discovery

Author

Albain, Kathy S., primary, Yau, Christina, primary, Petricoin, Emanuel F., primary, Wolf, Denise M., primary, Lang, Julie E., primary, Chien, A. Jo, primary, Haddad, Tufia, primary, Forero-Torres, Andres, primary, Wallace, Anne M., primary, Kaplan, Henry, primary, Pusztai, Lajos, primary, Euhus, David, primary, Nanda, Rita, primary, Elias, Anthony D., primary, Clark, Amy S., primary, Godellas, Constantine, primary, Boughey, Judy C., primary, Isaacs, Claudine, primary, Tripathy, Debu, primary, Lu, Janice, primary, Yung, Rachel L., primary, Gallagher, Rosa I., primary, Wulfkuhle, Julia D., primary, Brown-Swigart, Lamorna, primary, Krings, Gregor, primary, Chen, Yunn Yi, primary, Potter, David A., primary, Stringer-Reasor, Erica, primary, Blair, Sarah, primary, Asare, Smita M., primary, Wilson, Amy, primary, Hirst, Gillian L., primary, Singhrao, Ruby, primary, Buxton, Meredith, primary, Clennell, Julia L., primary, Sanil, Ashish, primary, Berry, Scott, primary, Asare, Adam L., primary, Matthews, Jeffrey B., primary, DeMichele, Angela M., primary, Hylton, Nola M., primary, Melisko, Michelle, primary, Perlmutter, Jane, primary, Rugo, Hope S., primary, Symmans, W. Fraser, primary, van't Veer, Laura J., primary, Yee, Douglas, primary, Berry, Donald A., primary, and Esserman, Laura J., primary

Published
2024
Full Text
View/download PDF

8. Supplementary Figure S1 from Neoadjuvant Trebananib plus Paclitaxel-based Chemotherapy for Stage II/III Breast Cancer in the Adaptively Randomized I-SPY2 Trial—Efficacy and Biomarker Discovery

Author

Albain, Kathy S., primary, Yau, Christina, primary, Petricoin, Emanuel F., primary, Wolf, Denise M., primary, Lang, Julie E., primary, Chien, A. Jo, primary, Haddad, Tufia, primary, Forero-Torres, Andres, primary, Wallace, Anne M., primary, Kaplan, Henry, primary, Pusztai, Lajos, primary, Euhus, David, primary, Nanda, Rita, primary, Elias, Anthony D., primary, Clark, Amy S., primary, Godellas, Constantine, primary, Boughey, Judy C., primary, Isaacs, Claudine, primary, Tripathy, Debu, primary, Lu, Janice, primary, Yung, Rachel L., primary, Gallagher, Rosa I., primary, Wulfkuhle, Julia D., primary, Brown-Swigart, Lamorna, primary, Krings, Gregor, primary, Chen, Yunn Yi, primary, Potter, David A., primary, Stringer-Reasor, Erica, primary, Blair, Sarah, primary, Asare, Smita M., primary, Wilson, Amy, primary, Hirst, Gillian L., primary, Singhrao, Ruby, primary, Buxton, Meredith, primary, Clennell, Julia L., primary, Sanil, Ashish, primary, Berry, Scott, primary, Asare, Adam L., primary, Matthews, Jeffrey B., primary, DeMichele, Angela M., primary, Hylton, Nola M., primary, Melisko, Michelle, primary, Perlmutter, Jane, primary, Rugo, Hope S., primary, Symmans, W. Fraser, primary, van't Veer, Laura J., primary, Yee, Douglas, primary, Berry, Donald A., primary, and Esserman, Laura J., primary

Published
2024
Full Text
View/download PDF

9. Supplementary Table S2 from Neoadjuvant Trebananib plus Paclitaxel-based Chemotherapy for Stage II/III Breast Cancer in the Adaptively Randomized I-SPY2 Trial—Efficacy and Biomarker Discovery

Author

Albain, Kathy S., primary, Yau, Christina, primary, Petricoin, Emanuel F., primary, Wolf, Denise M., primary, Lang, Julie E., primary, Chien, A. Jo, primary, Haddad, Tufia, primary, Forero-Torres, Andres, primary, Wallace, Anne M., primary, Kaplan, Henry, primary, Pusztai, Lajos, primary, Euhus, David, primary, Nanda, Rita, primary, Elias, Anthony D., primary, Clark, Amy S., primary, Godellas, Constantine, primary, Boughey, Judy C., primary, Isaacs, Claudine, primary, Tripathy, Debu, primary, Lu, Janice, primary, Yung, Rachel L., primary, Gallagher, Rosa I., primary, Wulfkuhle, Julia D., primary, Brown-Swigart, Lamorna, primary, Krings, Gregor, primary, Chen, Yunn Yi, primary, Potter, David A., primary, Stringer-Reasor, Erica, primary, Blair, Sarah, primary, Asare, Smita M., primary, Wilson, Amy, primary, Hirst, Gillian L., primary, Singhrao, Ruby, primary, Buxton, Meredith, primary, Clennell, Julia L., primary, Sanil, Ashish, primary, Berry, Scott, primary, Asare, Adam L., primary, Matthews, Jeffrey B., primary, DeMichele, Angela M., primary, Hylton, Nola M., primary, Melisko, Michelle, primary, Perlmutter, Jane, primary, Rugo, Hope S., primary, Symmans, W. Fraser, primary, van't Veer, Laura J., primary, Yee, Douglas, primary, Berry, Donald A., primary, and Esserman, Laura J., primary

Published
2024
Full Text
View/download PDF

10. Supplementary Methods S1 from Neoadjuvant Trebananib plus Paclitaxel-based Chemotherapy for Stage II/III Breast Cancer in the Adaptively Randomized I-SPY2 Trial—Efficacy and Biomarker Discovery

Author

Albain, Kathy S., primary, Yau, Christina, primary, Petricoin, Emanuel F., primary, Wolf, Denise M., primary, Lang, Julie E., primary, Chien, A. Jo, primary, Haddad, Tufia, primary, Forero-Torres, Andres, primary, Wallace, Anne M., primary, Kaplan, Henry, primary, Pusztai, Lajos, primary, Euhus, David, primary, Nanda, Rita, primary, Elias, Anthony D., primary, Clark, Amy S., primary, Godellas, Constantine, primary, Boughey, Judy C., primary, Isaacs, Claudine, primary, Tripathy, Debu, primary, Lu, Janice, primary, Yung, Rachel L., primary, Gallagher, Rosa I., primary, Wulfkuhle, Julia D., primary, Brown-Swigart, Lamorna, primary, Krings, Gregor, primary, Chen, Yunn Yi, primary, Potter, David A., primary, Stringer-Reasor, Erica, primary, Blair, Sarah, primary, Asare, Smita M., primary, Wilson, Amy, primary, Hirst, Gillian L., primary, Singhrao, Ruby, primary, Buxton, Meredith, primary, Clennell, Julia L., primary, Sanil, Ashish, primary, Berry, Scott, primary, Asare, Adam L., primary, Matthews, Jeffrey B., primary, DeMichele, Angela M., primary, Hylton, Nola M., primary, Melisko, Michelle, primary, Perlmutter, Jane, primary, Rugo, Hope S., primary, Symmans, W. Fraser, primary, van't Veer, Laura J., primary, Yee, Douglas, primary, Berry, Donald A., primary, and Esserman, Laura J., primary

Published
2024
Full Text
View/download PDF

11. Supplementary Methods S1 from Neoadjuvant Trebananib plus Paclitaxel-based Chemotherapy for Stage II/III Breast Cancer in the Adaptively Randomized I-SPY2 Trial—Efficacy and Biomarker Discovery

Author

Albain, Kathy S., primary, Yau, Christina, primary, Petricoin, Emanuel F., primary, Wolf, Denise M., primary, Lang, Julie E., primary, Chien, A. Jo, primary, Haddad, Tufia, primary, Forero-Torres, Andres, primary, Wallace, Anne M., primary, Kaplan, Henry, primary, Pusztai, Lajos, primary, Euhus, David, primary, Nanda, Rita, primary, Elias, Anthony D., primary, Clark, Amy S., primary, Godellas, Constantine, primary, Boughey, Judy C., primary, Isaacs, Claudine, primary, Tripathy, Debu, primary, Lu, Janice, primary, Yung, Rachel L., primary, Gallagher, Rosa I., primary, Wulfkuhle, Julia D., primary, Brown-Swigart, Lamorna, primary, Krings, Gregor, primary, Chen, Yunn Yi, primary, Potter, David A., primary, Stringer-Reasor, Erica, primary, Blair, Sarah, primary, Asare, Smita M., primary, Wilson, Amy, primary, Hirst, Gillian L., primary, Singhrao, Ruby, primary, Buxton, Meredith, primary, Clennell, Julia L., primary, Sanil, Ashish, primary, Berry, Scott, primary, Asare, Adam L., primary, Matthews, Jeffrey B., primary, DeMichele, Angela M., primary, Hylton, Nola M., primary, Melisko, Michelle, primary, Perlmutter, Jane, primary, Rugo, Hope S., primary, Symmans, W. Fraser, primary, van't Veer, Laura J., primary, Yee, Douglas, primary, Berry, Donald A., primary, and Esserman, Laura J., primary

Published
2024
Full Text
View/download PDF

12. Supplementary Figure S1 from Neoadjuvant Trebananib plus Paclitaxel-based Chemotherapy for Stage II/III Breast Cancer in the Adaptively Randomized I-SPY2 Trial—Efficacy and Biomarker Discovery

Author

Albain, Kathy S., primary, Yau, Christina, primary, Petricoin, Emanuel F., primary, Wolf, Denise M., primary, Lang, Julie E., primary, Chien, A. Jo, primary, Haddad, Tufia, primary, Forero-Torres, Andres, primary, Wallace, Anne M., primary, Kaplan, Henry, primary, Pusztai, Lajos, primary, Euhus, David, primary, Nanda, Rita, primary, Elias, Anthony D., primary, Clark, Amy S., primary, Godellas, Constantine, primary, Boughey, Judy C., primary, Isaacs, Claudine, primary, Tripathy, Debu, primary, Lu, Janice, primary, Yung, Rachel L., primary, Gallagher, Rosa I., primary, Wulfkuhle, Julia D., primary, Brown-Swigart, Lamorna, primary, Krings, Gregor, primary, Chen, Yunn Yi, primary, Potter, David A., primary, Stringer-Reasor, Erica, primary, Blair, Sarah, primary, Asare, Smita M., primary, Wilson, Amy, primary, Hirst, Gillian L., primary, Singhrao, Ruby, primary, Buxton, Meredith, primary, Clennell, Julia L., primary, Sanil, Ashish, primary, Berry, Scott, primary, Asare, Adam L., primary, Matthews, Jeffrey B., primary, DeMichele, Angela M., primary, Hylton, Nola M., primary, Melisko, Michelle, primary, Perlmutter, Jane, primary, Rugo, Hope S., primary, Symmans, W. Fraser, primary, van't Veer, Laura J., primary, Yee, Douglas, primary, Berry, Donald A., primary, and Esserman, Laura J., primary

Published
2024
Full Text
View/download PDF

13. Table S2 from Characteristics and Spatially Defined Immune (micro)landscapes of Early-stage PD-L1–positive Triple-negative Breast Cancer

Author

Carter, Jodi M., primary, Polley, Mei-Yin C., primary, Leon-Ferre, Roberto A., primary, Sinnwell, Jason, primary, Thompson, Kevin J., primary, Wang, Xue, primary, Ma, Yaohua, primary, Zahrieh, David, primary, Kachergus, Jennifer M., primary, Solanki, Malvika, primary, Boughey, Judy C., primary, Liu, Minetta C., primary, Ingle, James N., primary, Kalari, Krishna R., primary, Couch, Fergus J., primary, Thompson, E. Aubrey, primary, and Goetz, Matthew P., primary

Published
2023
Full Text
View/download PDF

30. Data from Quantitative Analysis of Tyrosine Phosphorylation from FFPE Tissues Reveals Patient-Specific Signaling Networks

Author

Kohale, Ishwar N., primary, Burgenske, Danielle M., primary, Mladek, Ann C., primary, Bakken, Katrina K., primary, Kuang, Jenevieve, primary, Boughey, Judy C., primary, Wang, Liewei, primary, Carter, Jodi M., primary, Haura, Eric B., primary, Goetz, Matthew P., primary, Sarkaria, Jann N., primary, and White, Forest M., primary

Published
2023
Full Text
View/download PDF

31. Supplementary Tables from A Transcriptionally Definable Subgroup of Triple-Negative Breast and Ovarian Cancer Samples Shows Sensitivity to HSP90 Inhibition

Author

Shee, Kevin, primary, Wells, Jason D., primary, Ung, Matthew, primary, Hampsch, Riley A., primary, Traphagen, Nicole A., primary, Yang, Wei, primary, Liu, Stephanie C., primary, Zeldenrust, Megan A., primary, Wang, Liewei, primary, Kalari, Krishna R., primary, Yu, Jia, primary, Boughey, Judy C., primary, Demidenko, Eugene, primary, Kettenbach, Arminja N., primary, Cheng, Chao, primary, Goetz, Matthew P., primary, and Miller, Todd W., primary

Published
2023
Full Text
View/download PDF

32. Supplementary Data from A Transcriptionally Definable Subgroup of Triple-Negative Breast and Ovarian Cancer Samples Shows Sensitivity to HSP90 Inhibition

Author

Shee, Kevin, primary, Wells, Jason D., primary, Ung, Matthew, primary, Hampsch, Riley A., primary, Traphagen, Nicole A., primary, Yang, Wei, primary, Liu, Stephanie C., primary, Zeldenrust, Megan A., primary, Wang, Liewei, primary, Kalari, Krishna R., primary, Yu, Jia, primary, Boughey, Judy C., primary, Demidenko, Eugene, primary, Kettenbach, Arminja N., primary, Cheng, Chao, primary, Goetz, Matthew P., primary, and Miller, Todd W., primary

Published
2023
Full Text
View/download PDF

33. Supplementary File 1 from Discovery of a Glucocorticoid Receptor (GR) Activity Signature Using Selective GR Antagonism in ER-Negative Breast Cancer

Author

West, Diana C., primary, Kocherginsky, Masha, primary, Tonsing-Carter, Eva Y., primary, Dolcen, D. Nesli, primary, Hosfield, David J., primary, Lastra, Ricardo R., primary, Sinnwell, Jason P., primary, Thompson, Kevin J., primary, Bowie, Kathleen R., primary, Harkless, Ryan V., primary, Skor, Maxwell N., primary, Pierce, Charles F., primary, Styke, Sarah C., primary, Kim, Caroline R., primary, de Wet, Larischa, primary, Greene, Geoffrey L., primary, Boughey, Judy C., primary, Goetz, Matthew P., primary, Kalari, Krishna R., primary, Wang, Liewei, primary, Fleming, Gini F., primary, Györffy, Balázs, primary, and Conzen, Suzanne D., primary

Published
2023
Full Text
View/download PDF

34. Supplementary Data from Quantitative Analysis of Tyrosine Phosphorylation from FFPE Tissues Reveals Patient-Specific Signaling Networks

Author

Kohale, Ishwar N., primary, Burgenske, Danielle M., primary, Mladek, Ann C., primary, Bakken, Katrina K., primary, Kuang, Jenevieve, primary, Boughey, Judy C., primary, Wang, Liewei, primary, Carter, Jodi M., primary, Haura, Eric B., primary, Goetz, Matthew P., primary, Sarkaria, Jann N., primary, and White, Forest M., primary

Published
2023
Full Text
View/download PDF

35. Supplementary Figures from Inhibition of ATM Induces Hypersensitivity to Proton Irradiation by Upregulating Toxic End Joining

Author

Zhou, Qin, primary, Howard, Michelle E., primary, Tu, Xinyi, primary, Zhu, Qian, primary, Denbeigh, Janet M., primary, Remmes, Nicholas B., primary, Herman, Michael G., primary, Beltran, Chris J., primary, Yuan, Jian, primary, Greipp, Patricia T., primary, Boughey, Judy C., primary, Wang, Liewei, primary, Johnson, Neil, primary, Goetz, Matthew P., primary, Sarkaria, Jann N., primary, Lou, Zhenkun, primary, and Mutter, Robert W., primary

Published
2023
Full Text
View/download PDF

36. Supplementary Data from Quantitative Analysis of Tyrosine Phosphorylation from FFPE Tissues Reveals Patient-Specific Signaling Networks

Author

Kohale, Ishwar N., primary, Burgenske, Danielle M., primary, Mladek, Ann C., primary, Bakken, Katrina K., primary, Kuang, Jenevieve, primary, Boughey, Judy C., primary, Wang, Liewei, primary, Carter, Jodi M., primary, Haura, Eric B., primary, Goetz, Matthew P., primary, Sarkaria, Jann N., primary, and White, Forest M., primary

Published
2023
Full Text
View/download PDF

37. Supplementary File 2 from Discovery of a Glucocorticoid Receptor (GR) Activity Signature Using Selective GR Antagonism in ER-Negative Breast Cancer

Author

West, Diana C., primary, Kocherginsky, Masha, primary, Tonsing-Carter, Eva Y., primary, Dolcen, D. Nesli, primary, Hosfield, David J., primary, Lastra, Ricardo R., primary, Sinnwell, Jason P., primary, Thompson, Kevin J., primary, Bowie, Kathleen R., primary, Harkless, Ryan V., primary, Skor, Maxwell N., primary, Pierce, Charles F., primary, Styke, Sarah C., primary, Kim, Caroline R., primary, de Wet, Larischa, primary, Greene, Geoffrey L., primary, Boughey, Judy C., primary, Goetz, Matthew P., primary, Kalari, Krishna R., primary, Wang, Liewei, primary, Fleming, Gini F., primary, Györffy, Balázs, primary, and Conzen, Suzanne D., primary

Published
2023
Full Text
View/download PDF

38. Supplementary Information and Figures from Discovery of a Glucocorticoid Receptor (GR) Activity Signature Using Selective GR Antagonism in ER-Negative Breast Cancer

Author

West, Diana C., primary, Kocherginsky, Masha, primary, Tonsing-Carter, Eva Y., primary, Dolcen, D. Nesli, primary, Hosfield, David J., primary, Lastra, Ricardo R., primary, Sinnwell, Jason P., primary, Thompson, Kevin J., primary, Bowie, Kathleen R., primary, Harkless, Ryan V., primary, Skor, Maxwell N., primary, Pierce, Charles F., primary, Styke, Sarah C., primary, Kim, Caroline R., primary, de Wet, Larischa, primary, Greene, Geoffrey L., primary, Boughey, Judy C., primary, Goetz, Matthew P., primary, Kalari, Krishna R., primary, Wang, Liewei, primary, Fleming, Gini F., primary, Györffy, Balázs, primary, and Conzen, Suzanne D., primary

Published
2023
Full Text
View/download PDF

39. Supplementary Data from Pharmacological Targeting of Androgen Receptor Elicits Context-Specific Effects in Estrogen Receptor–Positive Breast Cancer

Author

Wei, Lixuan, primary, Gao, Huanyao, primary, Yu, Jia, primary, Zhang, Huan, primary, Nguyen, Thanh Thanh L., primary, Gu, Yayun, primary, Passow, Marie R., primary, Carter, Jodi M., primary, Qin, Bo, primary, Boughey, Judy C., primary, Goetz, Matthew P., primary, Weinshilboum, Richard M., primary, Ingle, James N., primary, and Wang, Liewei, primary

Published
2023
Full Text
View/download PDF

40. Supplementary Data from Quantitative Analysis of Tyrosine Phosphorylation from FFPE Tissues Reveals Patient-Specific Signaling Networks

Author

Kohale, Ishwar N., primary, Burgenske, Danielle M., primary, Mladek, Ann C., primary, Bakken, Katrina K., primary, Kuang, Jenevieve, primary, Boughey, Judy C., primary, Wang, Liewei, primary, Carter, Jodi M., primary, Haura, Eric B., primary, Goetz, Matthew P., primary, Sarkaria, Jann N., primary, and White, Forest M., primary

Published
2023
Full Text
View/download PDF

41. Supplementary File 1 from Discovery of a Glucocorticoid Receptor (GR) Activity Signature Using Selective GR Antagonism in ER-Negative Breast Cancer

Author

West, Diana C., primary, Kocherginsky, Masha, primary, Tonsing-Carter, Eva Y., primary, Dolcen, D. Nesli, primary, Hosfield, David J., primary, Lastra, Ricardo R., primary, Sinnwell, Jason P., primary, Thompson, Kevin J., primary, Bowie, Kathleen R., primary, Harkless, Ryan V., primary, Skor, Maxwell N., primary, Pierce, Charles F., primary, Styke, Sarah C., primary, Kim, Caroline R., primary, de Wet, Larischa, primary, Greene, Geoffrey L., primary, Boughey, Judy C., primary, Goetz, Matthew P., primary, Kalari, Krishna R., primary, Wang, Liewei, primary, Fleming, Gini F., primary, Györffy, Balázs, primary, and Conzen, Suzanne D., primary

Published
2023
Full Text
View/download PDF

42. Supplementary Data from Quantitative Analysis of Tyrosine Phosphorylation from FFPE Tissues Reveals Patient-Specific Signaling Networks

Author

Kohale, Ishwar N., primary, Burgenske, Danielle M., primary, Mladek, Ann C., primary, Bakken, Katrina K., primary, Kuang, Jenevieve, primary, Boughey, Judy C., primary, Wang, Liewei, primary, Carter, Jodi M., primary, Haura, Eric B., primary, Goetz, Matthew P., primary, Sarkaria, Jann N., primary, and White, Forest M., primary

Published
2023
Full Text
View/download PDF

43. Supplementary Data from Quantitative Analysis of Tyrosine Phosphorylation from FFPE Tissues Reveals Patient-Specific Signaling Networks

Author

Kohale, Ishwar N., primary, Burgenske, Danielle M., primary, Mladek, Ann C., primary, Bakken, Katrina K., primary, Kuang, Jenevieve, primary, Boughey, Judy C., primary, Wang, Liewei, primary, Carter, Jodi M., primary, Haura, Eric B., primary, Goetz, Matthew P., primary, Sarkaria, Jann N., primary, and White, Forest M., primary

Published
2023
Full Text
View/download PDF

44. Supplementary Data from Pharmacological Targeting of Androgen Receptor Elicits Context-Specific Effects in Estrogen Receptor–Positive Breast Cancer

Author

Wei, Lixuan, primary, Gao, Huanyao, primary, Yu, Jia, primary, Zhang, Huan, primary, Nguyen, Thanh Thanh L., primary, Gu, Yayun, primary, Passow, Marie R., primary, Carter, Jodi M., primary, Qin, Bo, primary, Boughey, Judy C., primary, Goetz, Matthew P., primary, Weinshilboum, Richard M., primary, Ingle, James N., primary, and Wang, Liewei, primary

Published
2023
Full Text
View/download PDF

45. Supplementary Figures from Inhibition of ATM Induces Hypersensitivity to Proton Irradiation by Upregulating Toxic End Joining

Author

Zhou, Qin, primary, Howard, Michelle E., primary, Tu, Xinyi, primary, Zhu, Qian, primary, Denbeigh, Janet M., primary, Remmes, Nicholas B., primary, Herman, Michael G., primary, Beltran, Chris J., primary, Yuan, Jian, primary, Greipp, Patricia T., primary, Boughey, Judy C., primary, Wang, Liewei, primary, Johnson, Neil, primary, Goetz, Matthew P., primary, Sarkaria, Jann N., primary, Lou, Zhenkun, primary, and Mutter, Robert W., primary

Published
2023
Full Text
View/download PDF

46. Supplementary File 3 from Discovery of a Glucocorticoid Receptor (GR) Activity Signature Using Selective GR Antagonism in ER-Negative Breast Cancer

Author

West, Diana C., primary, Kocherginsky, Masha, primary, Tonsing-Carter, Eva Y., primary, Dolcen, D. Nesli, primary, Hosfield, David J., primary, Lastra, Ricardo R., primary, Sinnwell, Jason P., primary, Thompson, Kevin J., primary, Bowie, Kathleen R., primary, Harkless, Ryan V., primary, Skor, Maxwell N., primary, Pierce, Charles F., primary, Styke, Sarah C., primary, Kim, Caroline R., primary, de Wet, Larischa, primary, Greene, Geoffrey L., primary, Boughey, Judy C., primary, Goetz, Matthew P., primary, Kalari, Krishna R., primary, Wang, Liewei, primary, Fleming, Gini F., primary, Györffy, Balázs, primary, and Conzen, Suzanne D., primary

Published
2023
Full Text
View/download PDF

47. Supplementary Data from Quantitative Analysis of Tyrosine Phosphorylation from FFPE Tissues Reveals Patient-Specific Signaling Networks

Author

Kohale, Ishwar N., primary, Burgenske, Danielle M., primary, Mladek, Ann C., primary, Bakken, Katrina K., primary, Kuang, Jenevieve, primary, Boughey, Judy C., primary, Wang, Liewei, primary, Carter, Jodi M., primary, Haura, Eric B., primary, Goetz, Matthew P., primary, Sarkaria, Jann N., primary, and White, Forest M., primary

Published
2023
Full Text
View/download PDF

48. Supplementary Data from Pharmacological Targeting of Androgen Receptor Elicits Context-Specific Effects in Estrogen Receptor–Positive Breast Cancer

Author

Wei, Lixuan, primary, Gao, Huanyao, primary, Yu, Jia, primary, Zhang, Huan, primary, Nguyen, Thanh Thanh L., primary, Gu, Yayun, primary, Passow, Marie R., primary, Carter, Jodi M., primary, Qin, Bo, primary, Boughey, Judy C., primary, Goetz, Matthew P., primary, Weinshilboum, Richard M., primary, Ingle, James N., primary, and Wang, Liewei, primary

Published
2023
Full Text
View/download PDF

49. Supplementary Data from Pharmacological Targeting of Androgen Receptor Elicits Context-Specific Effects in Estrogen Receptor–Positive Breast Cancer

Author

Wei, Lixuan, primary, Gao, Huanyao, primary, Yu, Jia, primary, Zhang, Huan, primary, Nguyen, Thanh Thanh L., primary, Gu, Yayun, primary, Passow, Marie R., primary, Carter, Jodi M., primary, Qin, Bo, primary, Boughey, Judy C., primary, Goetz, Matthew P., primary, Weinshilboum, Richard M., primary, Ingle, James N., primary, and Wang, Liewei, primary

Published
2023
Full Text
View/download PDF

50. Data from Quantitative Analysis of Tyrosine Phosphorylation from FFPE Tissues Reveals Patient-Specific Signaling Networks

Author

Kohale, Ishwar N., primary, Burgenske, Danielle M., primary, Mladek, Ann C., primary, Bakken, Katrina K., primary, Kuang, Jenevieve, primary, Boughey, Judy C., primary, Wang, Liewei, primary, Carter, Jodi M., primary, Haura, Eric B., primary, Goetz, Matthew P., primary, Sarkaria, Jann N., primary, and White, Forest M., primary

Published
2023
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results